세계의 히스토플라스마증 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망됩니다. 예측기간의 성장은 원격 의료 및 원격 진단, 환자 교육 및 지원, 상환 정책에 기인합니다. 예측 기간의 주요 동향에는 항진균제 내성 관리, 병용 요법, 면역 조절 요법, 고도 진단 도구가 포함됩니다.
만성 질환 증가는 향후 몇 년간의 히스토플라스마증 치료 시장의 성장을 이끌 것으로 예상됩니다. 히스토플라스마증 치료는 호흡기의 건강을 개선하고, 염증을 억제하고, 면역계 기능을 강화하고, 만성 질환을 앓는 환자의 삶의 질을 향상시킵니다. 2024년 6월 호주 정부 기관인 호주 보건복지연구소는 만성질환의 연령표준화 사망률이 인구 10만명당 448명으로, 2021년에는 10만명당 459명, 2022년에는 100,000명당 490명으로 더 상승할 것으로 보입니다.
인간 면역결핍 바이러스(HIV)의 유병률의 상승은 당분간의 히스토플라스마증 치료 시장 확대의 큰 원동력이 될 것으로 예측되고 있습니다. 2023년 7월 현재, 스위스에 본부를 두는 유엔기관인 세계보건기구(WHO)에 따르면, 2022년에 세계에서 보고된 HIV 감염자수는 3,900만명으로, HIV에 관련된 사망자수는 63만명입니다. 그 결과, HIV의 만연이 히스토플라스마증 치료 시장의 성장을 가속하는 요인이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 히스토플라스마증 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 히스토플라스마증 치료 시장 : 성장률 분석
- 세계의 히스토플라스마증 치료 시장 실적 : 규모와 성장, 2019-2024
- 세계의 히스토플라스마증 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034F
- 세계의 히스토플라스마증 치료 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 히스토플라스마증 치료 시장 : 약제 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 암포테리신 B
- 이트라코나졸
- 케토코나졸
- 기타 약제 유형
- 세계의 히스토플라스마증 치료 시장 : 투여 방법별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 주사
- 경구
- 기타 투여 방법
- 세계의 히스토플라스마증 치료 시장 : 환자 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 소아
- 성인
- 세계의 히스토플라스마증 치료 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 병원 약국
- 개인 클리닉
- 약국
- 소매 약국
- 전자상거래
- 기타 최종 사용자
- 세계의 히스토플라스마증 치료 시장 : 암포테리신 B 검사에 의한 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 리포좀 암포테리신 B
- 기존 암포테리신 B
- 세계의 히스토플라스마증 치료 시장 : 이트라코나졸 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 캡슐제
- 경구액제
- 세계의 히스토플라스마증 치료 시장 : 케토코나졸 세분화, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 경구 정제
- 외용 크림
- 세계의 히스토플라스마증 치료 시장 : 기타 약제 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 포사코나졸
- 보리코나졸
제7장 지역별 및 국가별 분석
- 세계의 히스토플라스마증 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
- 세계의 히스토플라스마증 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 히스토플라스마증 치료 시장 :경쟁 구도
- 히스토플라스마증 치료 시장 : 기업 프로파일
- Pfizer Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
- Johnson and Johnson Ltd. : 개요, 상품 및 서비스, 전략 및 재무분석
- F. Hoffmann-La Roche AG : 개요, 상품 및 서비스, 전략 및 재무분석
- Merck and Co. Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
- AbbVie Inc. : 개요, 상품 및 서비스, 전략 및 재무분석
제31장 기타 주요 기업 및 혁신 기업
- Novartis AG
- Sanofi SA
- Bristol Myers Squibb
- AstraZeneca Plc
- Abbott laboratories
- GSK Plc
- Eli Lilly and Company
- Gilead Sciences
- Teva Pharmaceutical Industries Ltd.
- Astellas pharma US Inc.
- Mylan NV
- Biogen Inc.
- Bausch Health Companies Inc.
- Mitsubishi Tanabe Pharma Corporation
- AB Science
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 히스토플라스마증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
- 히스토플라스마증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
- 히스토플라스마증 치료 시장(2029년) : 성장 전략
제36장 부록
JHS
Histoplasmosis treatment encompasses a range of medical interventions and therapies aimed at combatting the fungal infection caused by the Histoplasma capsulatum fungus. This particular fungus is commonly found in soil, especially in areas where substantial accumulations of bird or bat droppings exist. The approach to treatment is tailored to factors such as the infection's severity, the overall health of the patient, and the presence of any underlying medical conditions.
Histoplasmosis treatment encompasses a range of medical interventions and therapies aimed at combatting the fungal infection caused by the Histoplasma capsulatum fungus. This particular fungus is commonly found in soil, especially in areas where substantial accumulations of bird or bat droppings exist. The approach to treatment is tailored to factors such as the infection's severity, the overall health of the patient, and the presence of any underlying medical conditions.
The histoplasmosis treatment market research report is one of a series of new reports from The Business Research Company that provides histoplasmosis treatment market statistics, including histoplasmosis treatment industry global market size, regional shares, competitors with a histoplasmosis treatment market share, detailed histoplasmosis treatment market segments, market trends and opportunities and any further data you may need to thrive in the histoplasmosis treatment industry. This histoplasmosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The histoplasmosis treatment market size has grown strongly in recent years. It will grow from $5.13 billion in 2024 to $5.53 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to geographic prevalence, awareness and diagnosis, global health initiatives, research and drug development.
The histoplasmosis treatment market size is expected to see strong growth in the next few years. It will grow to $7.74 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to telemedicine and remote consultations, patient education and support, reimbursement policies. Major trends in the forecast period include antifungal resistance management, combination therapies, immunomodulatory therapies, advanced diagnostic tools.
The increasing prevalence of chronic diseases is expected to drive the growth of the histoplasmosis treatment market in the coming years. Chronic diseases are long-lasting conditions that persist for three months or more and may worsen over time. Histoplasmosis treatment helps improve respiratory health, reduce inflammation, enhance immune system function, and improve the quality of life for patients suffering from chronic diseases. For example, in June 2024, the Australian Institute of Health and Welfare, an Australia-based government agency, reported that the age-standardized death rate for chronic conditions was 448 per 100,000 population, rising to 459 per 100,000 in 2021 and further increasing to 490 per 100,000 in 2022. Therefore, the rising incidence of chronic diseases is driving the growth of the histoplasmosis treatment market.
The escalating prevalence of human immunodeficiency virus (HIV) is projected to be a major driving force behind the expansion of the histoplasmosis treatment market in the foreseeable future. HIV, a virus that targets CD4 cells (T cells) and weakens the immune system's ability to combat infections and diseases, has become increasingly prevalent. Histoplasmosis treatment plays a vital role in managing the fungal infection for AIDS patients, aiding in the prevention of disseminated disease and reducing mortality through the use of antifungal medications like itraconazole or amphotericin B. For instance, as of July 2023, according to the World Health Organization, a Switzerland-based United Nations agency, there were 39 million reported cases of HIV globally in 2022, resulting in 630,000 deaths from HIV-related causes. Consequently, the mounting prevalence of HIV is a key driver in the growth of the histoplasmosis treatment market.
Key players in the histoplasmosis treatment market are pioneering inventive approaches to fortify their market presence. Breakthroughs in antifungal drug research have paved the way for novel compounds and strategies specifically designed to combat invasive histoplasmosis. For instance, in June 2022, Apex Laboratories, an India-based pharmaceutical company, unveiled an advanced iteration of Itraconazole Capsules Supra Bioavailable in 65 and 130 mg variants-a potent therapeutic option for effectively managing fungal infections. These capsules deliver a remarkable 90% of active medicine to the biological system at a reduced dosage, catering to a range of fungal infections like blastomycosis, histoplasmosis, and aspergillosis. Their creation involves cutting-edge spray granulation technology, which accelerates the dissolution rate of itraconazole. This medication is uniformly present in solid dispersion, sans pellets. Such innovative techniques enhance the bioavailability of medications with low solubility.
Major companies operating in the histoplasmosis treatment market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A, Bristol Myers Squibb, AstraZeneca PLC, Abbott laboratories, GSK PLC, Eli Lilly and Company, Gilead Sciences, Teva Pharmaceutical Industries Ltd., Astellas pharma US Inc., Mylan N.V., Biogen Inc., Bausch Health Companies Inc., Mitsubishi Tanabe Pharma Corporation, AB Science, Ionis Pharmaceuticals Inc., Advanz Pharma Corp., Leadiant Biosciences, IMMY, Sigma Tau Pharmaceuticals Inc.
North America was the largest region in the histoplasmosis treatment market in 2024. The regions covered in histoplasmosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the histoplasmosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The histoplasmosis treatment consists of sales of antifungal medications and posaconazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Histoplasmosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on histoplasmosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for histoplasmosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The histoplasmosis treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Drug Type: Amphotericin B; Itraconazole; Ketoconazole; Other Drug Type
- 2) By Mode of Administration: Injectable; Oral; Other Mode Of Administration
- 3) By Patient Type: Pediatric; Adult
- 4) By End-User: Hospital Pharmacies; Private Clinics; Drug Stores; Retail Pharmacies; E-Commerce; Other End-Users
- Subsegments:
- 1) By Amphotericin B: Liposomal Amphotericin B; Conventional Amphotericin B
- 2) By Itraconazole: Capsule Form; Oral Solution
- 3) By Ketoconazole: Oral Tablets; Topical Creams
- 4) By Other Drug Type: Posaconazole; Voriconazole
- Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; F. Hoffmann-La Roche AG; Merck and Co. Inc.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Histoplasmosis Treatment Market Characteristics
3. Histoplasmosis Treatment Market Trends And Strategies
4. Histoplasmosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Histoplasmosis Treatment Growth Analysis And Strategic Analysis Framework
- 5.1. Global Histoplasmosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Histoplasmosis Treatment Market Growth Rate Analysis
- 5.4. Global Histoplasmosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Histoplasmosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Histoplasmosis Treatment Total Addressable Market (TAM)
6. Histoplasmosis Treatment Market Segmentation
- 6.1. Global Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Amphotericin B
- Itraconazole
- Ketoconazole
- Other Drug Type
- 6.2. Global Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Injectable
- Oral
- Other Mode Of Administration
- 6.3. Global Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pediatric
- Adult
- 6.4. Global Histoplasmosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Private Clinics
- Drug Stores
- Retail Pharmacies
- E-Commerce
- Other End-Users
- 6.5. Global Histoplasmosis Treatment Market, Sub-Segmentation Of Amphotericin B, By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Liposomal Amphotericin B
- Conventional Amphotericin B
- 6.6. Global Histoplasmosis Treatment Market, Sub-Segmentation Of Itraconazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Capsule Form
- Oral Solution
- 6.7. Global Histoplasmosis Treatment Market, Sub-Segmentation Of Ketoconazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral Tablets
- Topical Creams
- 6.8. Global Histoplasmosis Treatment Market, Sub-Segmentation Of Other Drug Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Posaconazole
- Voriconazole
7. Histoplasmosis Treatment Market Regional And Country Analysis
- 7.1. Global Histoplasmosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Histoplasmosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Histoplasmosis Treatment Market
- 8.1. Asia-Pacific Histoplasmosis Treatment Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Histoplasmosis Treatment Market
- 9.1. China Histoplasmosis Treatment Market Overview
- 9.2. China Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Histoplasmosis Treatment Market
- 10.1. India Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Histoplasmosis Treatment Market
- 11.1. Japan Histoplasmosis Treatment Market Overview
- 11.2. Japan Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Histoplasmosis Treatment Market
- 12.1. Australia Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Histoplasmosis Treatment Market
- 13.1. Indonesia Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Histoplasmosis Treatment Market
- 14.1. South Korea Histoplasmosis Treatment Market Overview
- 14.2. South Korea Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Histoplasmosis Treatment Market
- 15.1. Western Europe Histoplasmosis Treatment Market Overview
- 15.2. Western Europe Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Histoplasmosis Treatment Market
- 16.1. UK Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Histoplasmosis Treatment Market
- 17.1. Germany Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Histoplasmosis Treatment Market
- 18.1. France Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Histoplasmosis Treatment Market
- 19.1. Italy Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Histoplasmosis Treatment Market
- 20.1. Spain Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Histoplasmosis Treatment Market
- 21.1. Eastern Europe Histoplasmosis Treatment Market Overview
- 21.2. Eastern Europe Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Histoplasmosis Treatment Market
- 22.1. Russia Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Histoplasmosis Treatment Market
- 23.1. North America Histoplasmosis Treatment Market Overview
- 23.2. North America Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Histoplasmosis Treatment Market
- 24.1. USA Histoplasmosis Treatment Market Overview
- 24.2. USA Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Histoplasmosis Treatment Market
- 25.1. Canada Histoplasmosis Treatment Market Overview
- 25.2. Canada Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Histoplasmosis Treatment Market
- 26.1. South America Histoplasmosis Treatment Market Overview
- 26.2. South America Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Histoplasmosis Treatment Market
- 27.1. Brazil Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Histoplasmosis Treatment Market
- 28.1. Middle East Histoplasmosis Treatment Market Overview
- 28.2. Middle East Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Histoplasmosis Treatment Market
- 29.1. Africa Histoplasmosis Treatment Market Overview
- 29.2. Africa Histoplasmosis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Histoplasmosis Treatment Market, Segmentation By Mode of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Histoplasmosis Treatment Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Histoplasmosis Treatment Market Competitive Landscape And Company Profiles
- 30.1. Histoplasmosis Treatment Market Competitive Landscape
- 30.2. Histoplasmosis Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Histoplasmosis Treatment Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi S.A
- 31.3. Bristol Myers Squibb
- 31.4. AstraZeneca Plc
- 31.5. Abbott laboratories
- 31.6. GSK Plc
- 31.7. Eli Lilly and Company
- 31.8. Gilead Sciences
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Astellas pharma US Inc.
- 31.11. Mylan N.V.
- 31.12. Biogen Inc.
- 31.13. Bausch Health Companies Inc.
- 31.14. Mitsubishi Tanabe Pharma Corporation
- 31.15. AB Science
32. Global Histoplasmosis Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Histoplasmosis Treatment Market
34. Recent Developments In The Histoplasmosis Treatment Market
35. Histoplasmosis Treatment Market High Potential Countries, Segments and Strategies
- 35.1 Histoplasmosis Treatment Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Histoplasmosis Treatment Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Histoplasmosis Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
